Dyanavel XR Approval History
Dyanavel XR (amphetamine) is an extended-release central nervous system (CNS) stimulant in an oral suspension formulation for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Development History and FDA Approval Process for Dyanavel XR
|Oct 20, 2015||Tris Pharma Receives FDA Approval of Dyanavel XR (amphetamine) Once-Daily Liquid for ADHD in Children|
|May 21, 2015||Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel XR|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.